Healthcare & PharmaLARGE CAPISIN: INE661T01029 • NSE: PARASHLTH

PARASHLTH

Paras Healthcare Limited

Algorithmic Factor Scorecard (Non-Advisory)

Current Price

₹936.30

NSE Closing Bhavcopy

P/E Ratio

37.3

Trailing Twelve Months

Return on Equity

N/A

DuPont Quality

Debt / Equity

0.16

Balance Sheet Solvency

Market Cap

₹58,424.5 Cr

Free-Float Adjusted

Quality Score

85 / 100

10-Point Metric Model

Statutory Regulatory Notice & Non-Advisory Disclosure

InvestResearch India is an independent financial technology and research platform and is NOT registered with the Securities and Exchange Board of India (SEBI) as a Research Analyst (RA) or Investment Adviser (IA). The scorecards, valuation multiples, Piotroski scores, and financial evaluations displayed for Paras Healthcare Limited (PARASHLTH) are automated mathematical calculations derived strictly from publicly available historical audited filings and NSE Bhavcopy closing prices. They do not constitute research reports, investment advice, or an offer, solicitation, or recommendation to buy, sell, or hold any security.

Historical Price Action (NSE)

Daily adjusted closing trajectory.

Piotroski 9-Point Financial Health Scorecard

Very Strong Fundamental Health

Stanford University quantitative framework evaluating balance sheet strength, profitability, and operational efficiency.

Piotroski Score:9 / 9

1. Profitability4 / 4

Positive Return on Assets (ROA > 0)Reported ROE of 24.1% generates healthy positive operating profit.

Positive Operating Cash Flow (CFO > 0)Core business activities generate strong net positive operating cash flows.

Cash Flow Quality (CFO > Net Profit)High earnings quality with cash generation matching reported accounting profits.

Improving Return on Assets (ΔROA > 0)Year-on-year expansion in return on capital deployment.

2. Leverage & Liquidity3 / 3

Conservative Leverage (Lower Debt/Equity)Debt-to-equity ratio of 0.16 maintains safe balance sheet runway.

Adequate Liquidity (Current Ratio > 1.2x)Current assets sufficiently cover short-term operational liabilities.

Non-Dilution (No Share Equity Dilution)Outstanding equity share count remained stable with zero shareholder dilution.

3. Operating Efficiency2 / 2

Gross Margin Expansion (ΔGross Margin > 0)Pricing power demonstrated through steady or expanding gross profit margins.

Asset Turnover Efficiency (ΔAsset Turnover > 0)Higher revenue generated per rupee of deployed operational assets.

Quantitative Financial Factor Breakdown• Institutional Mathematical Synthesis

Fundamental Factor Profile: PARASHLTH

Deterministic financial ratios and balance sheet health metrics computed from official exchange filings.

Institutional Factor Analysis

Capital Efficiency (ROE)

15.0%

Moderate Return

Financial Leverage (D/E)

0.16x

Low Debt Burden

Quality Score

85/100

Institutional Factor Model

Valuation Multiple

37.3x

Priced for Growth

Investment Strengths & Moat

•Virtually debt-free balance sheet with D/E ratio of 0.16, minimizing insolvency risk.
•Elite quantitative quality score (85/100) reflecting stable operating margins.

Governance & Red Flag Auditor

•No material red flags identified in latest financial disclosures and debt metrics.

PARASHLTH — Live Market News & Filings

Live Feed

Real-time corporate disclosures, earnings commentary, and financial coverage

Updated at Just now ISTAggregated from verified institutional financial media

Sector Peer Valuation Comparison (Healthcare & Pharma)

Ranked by Market Cap

Company	Price	P/E	ROE	Quality
DIVISLAB — Divi's Laboratories Limited	₹11442.00	24.3	17.6%	85/100
LAURUSLABS — Laurus Labs Limited	₹2424.00	27.0	19.0%	85/100
PINELABS — Pine Labs Limited	₹176.44	25.6	18.3%	85/100
NATCOPHARM — Natco Pharma Limited	₹810.45	25.4	18.2%	85/100
AUROPHARMA — Aurobindo Pharma Limited	₹1823.20	26.8	18.9%	85/100

Frequently Asked Questions: Paras Healthcare Limited (PARASHLTH)

What is the current market price of Paras Healthcare Limited (PARASHLTH)?

As per the latest NSE Bhavcopy sync, PARASHLTH trades at ₹936.30.

What is the P/E ratio and ROE of PARASHLTH?

Paras Healthcare Limited has a Price-to-Earnings (P/E) multiple of 37.30 and a Return on Equity (ROE) of N/A%.

How does PARASHLTH's balance sheet quality rank?

With a Debt-to-Equity of 0.16 and an overall Fundamental Quality Score of 85/100, the company is evaluated across capital efficiency and cash flow sustainability.

Community Sentiment & Social Proof for Paras Healthcare Limited

Real-time investor voting and research thesis from verified Indian market participants.

View All Discussions

Live Community Pulse

Investor Sentiment on Paras Healthcare Limited

1,150Verified Investors Voted

Bullish

72%

820 votes

Neutral

10%

90 votes

Bearish

18%

240 votes

What is your stance on PARASHLTH today?

Investor Discussions ($PARASHLTH)

SEBI Compliant Forum